Is MVRBF or NNN a better dividend investment in 2026?

MVRBF currently yields 243.90% with a 5% 5-year dividend growth rate. NNN yields 5.68% with 2.8% growth. The better choice depends on your goal: MVRBF offers higher current income.

What is the dividend yield difference between MVRBF and NNN?

MVRBF has a forward dividend yield of 243.90% ($2.00/share annually). NNN yields 5.68% ($2.38/share annually). The yield gap is 238.22 percentage points.

Home › Compare › MVRBF vs NNN

MVRBF vs NNN: Dividend Comparison 2026

MVRBF yields 243.90% · NNN yields 5.68%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MVRBF wins by $394.59M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MVRBF

● Live price

243.90%

Share price

$0.82

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$394.62M

Annual income

$218,439,906.42

Full MVRBF calculator →

NNN

NNN REIT Inc.

● Live price

5.68%

Share price

$41.89

Annual div

$2.38

5Y div CAGR

8.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.6K

Annual income

$2,637.42

Full NNN calculator →

Portfolio growth — MVRBF vs NNN

📍 MVRBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MVRBF	NNN
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MVRBF + NNN cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MVRBF pays

NNN pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MVRBF

Annual income on $10K today (after 15% tax)

$20,731.71/yr

After 10yr DRIP, annual income (after tax)

$185,673,920.46/yr

NNN

Annual income on $10K today (after 15% tax)

$482.93/yr

After 10yr DRIP, annual income (after tax)

$2,241.81/yr

At 15% tax rate, MVRBF beats the other by $185,671,678.65/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MVRBF + NNN for your $10,000?

MVRBF: 50%NNN: 50%

100% NNN50/50100% MVRBF

Portfolio after 10yr

$197.32M

Annual income

$109,221,271.92/yr

Blended yield

55.35%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

MVRBF

No analyst data

Altman Z

1.7

Piotroski

0/9

NNN

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$44.93

+7.3% upside vs current

Range: $43.00 — $48.50

Altman Z

1.1

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MVRBF buys

NNN buys

No recent congressional trades found for MVRBF or NNN in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMVRBFNNN

Forward yield	243.90% ✓	5.68%
Annual dividend / share	$2.00	$2.38 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	8.6% ✓
Portfolio after 10y	$394.62M ✓	$25.6K
Annual income after 10y	$218,439,906.42 ✓	$2,637.42
Total dividends collected	$375.65M ✓	$13.7K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: MVRBF vs NNN ($10,000, DRIP)

Year	MVRBF Portfolio	MVRBF Income/yr	NNN Portfolio	NNN Income/yr	Gap
1← crossover	$35,090	$24,390.24	$10,737	$617.02	+$24.4K → MVRBF
2	$117,533	$79,986.88	$11,577	$710.93	+$106.0K → MVRBF
3	$376,147	$250,386.00	$12,538	$822.59	+$363.6K → MVRBF
4	$1,151,374	$748,897.11	$13,645	$956.06	+$1.14M → MVRBF
5	$3,374,355	$2,142,384.97	$14,925	$1,116.51	+$3.36M → MVRBF
6	$9,478,533	$5,867,972.46	$16,415	$1,310.57	+$9.46M → MVRBF
7	$25,546,778	$15,404,747.63	$18,158	$1,546.77	+$25.53M → MVRBF
8	$66,138,099	$38,803,046.68	$20,213	$1,836.20	+$66.12M → MVRBF
9	$164,653,072	$93,885,306.32	$22,649	$2,193.37	+$164.63M → MVRBF
10	$394,618,693	$218,439,906.42	$25,558	$2,637.42	+$394.59M → MVRBF

MVRBF vs NNN: Complete Analysis 2026

MVRBF — Stock

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.

Full MVRBF Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →

📬

Get this MVRBF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MVRBF vs SCHD MVRBF vs JEPI MVRBF vs O MVRBF vs KO MVRBF vs MAIN MVRBF vs ADC MVRBF vs EPRT MVRBF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.